An Imbalanced GLP-1R/GIPR Co-Agonist Peptide with a Site-Specific N-terminal PEGylation to Maximize Metabolic Benefits
iScience（2024）
Key words
Glucagon-like peptide 1 receptor,Glucose-dependent insulinotropic polypeptide receptor,Imbalanced agonist,Site-specific PEGylation,Diabetes,Obesity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined